Infectious agents and the etiology of chronic idiopathic diseases

Current Clinical Topics in Infectious Diseases

Volumn , Issue 18, 1998, Pages 180-200

  Fredricks, David N ^a   Relman, David A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; CHRONIC DISEASE; CROHN DISEASE; HUMAN; INFECTION; INTESTINE LIPODYSTROPHY; KAPOSI SARCOMA; LYME DISEASE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PEPTIC ULCER; REVIEW; RHEUMATIC DISEASE; SARCOIDOSIS; TROPICAL SPRUE; VIRUS INFECTION;

ARTERIOSCLEROSIS; CHRONIC DISEASE; CROHN DISEASE; HANTAVIRUS INFECTIONS; HUMANS; INFECTION; LYME DISEASE; MICROBIOLOGICAL TECHNIQUES; PEPTIC ULCER; RHEUMATIC DISEASES; SARCOIDOSIS; SARCOMA, KAPOSI; SPRUE, TROPICAL; WHIPPLE DISEASE;

EID: 0031602655     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (90)

1. Whipple GE. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Johns Hopkins Hosp Bull 1907;18:382-391.
2. Denholm RB, Mills PR, More IA. Electron microscopy in the long-term follow-up of Whipple's disease. Effect of antibiotics. Am J Surg Pathol 1981;5:507-516.
3. Silva MT, Macedo PM, Moura NJ. Ultrastructure of bacilli and the bacillary origin of the macrophagic inclusions in Whipple's disease. J Gen Microbiol 1985;131:1001-1013.
4. Relman DA. Whipple's disease. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:919-936.
5. Paulley JW. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 1952;22:128-133.
6. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991; 338:474-475.
7. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease [comments]. N Engl J Med 1992;327:293-301.
8. Ramzan NN, Loftus EJ, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 1997;126:520-527.
9. Ward DM, Weller R, Bateson MM. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community [comments]. Nature 1990;345:63-65.
10. Barns SM, Fundyga RE, Jeffries MW, Pace NR. Remarkable archaeal diversity detected in a Yellowstone National Park hot spring environment [comments]. Proc Natl Acad Sci USA 1994;91:1609-1613.
11. Liesack W, Stackebrandt E. Occurrence of novel groups of the domain Bacteria as revealed by analysis of genetic material isolated from an Australian terrestrial environment. J Bacteriol 1992;174:5072-5078.
12. Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996;62: 2273-2278.
13. Wagner M, Assmus B, Hartmann A, Hutzler P, Amann R. In situ analysis of microbial consortia in activated sludge using fluorescently labelled, rRNA-targeted oligonucleotide probes and confocal scanning laser microscopy. J Microsc 1994;176:181-187.
14. Evans AS. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976;49:175-195.
15. Marley JE, McMichael AJ. Principles behind practice. 6. Disease causation. The role of epidemiological evidence. Med J Aust 1991; 155:95-101.
16. Fredricks DN, Relman DA. Sequence-based evidence of microbial disease causation: when Koch's postulates don't fit. J NIH Research 1996;8:39-44.
17. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
18. Chapman LE, Khabbaz RF. Etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis 1994;3:234-244.
19. Zaki SR, Khan AS, Goodman RA, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch Pathol Lab Med 1996;120:134-139.
20. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med 1994;330:949-955.
21. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990;69:307-316.
22. Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994; 51:102-108.
23. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20:7-17.
24. Steere AC, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH. Antibiotic therapy in Lyme disease. Ann Intern Med 1980;93:1-8.
25. Persing DH, Telford S3, Rys PN, et al. Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks. Science 1990;249:1420-1423.
26. Marshall WF, Telford S3, Rys PN, et al. Detection of Borrelia burgdorferi DNA in museum specimens of Peromyscus leucopus. J Infect Dis 1994;170:1027-1032.
27. Tytgat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin N Am 1993;22:127-139.
28. Blasser MJ. Bacteria and diseases of unknown cause [editorial]. Ann Intern Med 1994;121: 144-145.
29. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-951.
30. Wang Z, Brown DD. A gene expression screen. Proc Natl Acad Sci USA 1991;88: 11505-11509.
31. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
32. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-346.
33. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335: 233-241.
34. Moake JL. Haemolytic-uraemic syndrome: basic science [comments]. Lancet 1994;343: 393-397.
35. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Molec Microbiol 1997; 23:1089-1097.
36. Ewald PW. Guarding against the most dangerous emerging pathogens. Emerg Infect Dis 1996;2:245-257.
37. Branley J, Wolfson C, Waters P, Gottlieb T, Bradbury R. Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat population. Pathology 1996;28:262-265.
38. Chomel BB, Abbott RC, Kasten RW, et al. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol 1995;33:2445-2450.
39. Burmester GR, Solbach W. Hit and run, hit and hide or permanent hit: why it is premature to dump Koch's postulates in rheumatic diseases [editorial]. J Rheumatol 1992;19:1173-1174.
40. Crohn B, Ginsburg L, Oppenheimer G. Regional ileitis, a pathological and clinical entity. J Am Med Assoc 1932;99:1323-1329.
41. Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991;325:1008-1016.
42. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928-937.
43. Cocito C, Gilot P, Coene M, de Kessel M, Poupart P, Vannuffel P. Paratuberculosis. Clin Microbiol Rev 1994;7:328-345.
44. Sanderson JD, Moss MT, Tizard ML, Hermon TJ. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33: 890-896.
45. Moss MT, Sanderson JD, lizard ML, et al. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut 1992;33:1209-1213.
46. Fidler HM, Thurrell W, Johnson NM, Rook GA, McFadden JJ. Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut 1994;35:506-510.
47. Dell'Isola B, Poyart C, Goulet O, et al. Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis 1994;169:449-451.
48. Miyamoto H, Tanaka T, Kitamoto N, Fukuda Y, Shimoyama T. Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease. J Gastroenterol 1995;30: 28-33.
49. Smith MS, Wakefield AJ. Viral association with Crohn's disease. Ann Med 1993;25: 557-561.
50. Wakefield AJ, Fox JD, Sawyerr AM, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992;38:183-190.
51. Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993;39:345-353.
52. Gray GM. Tropical sprue: chronic intestinal malabsorption in the tropics. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:333-341.
53. Klipstein FA, Falaiye JM. Tropical sprue in expatriates from the tropics living in the continental United States. Medicine (Baltimore) 1969;48:475-491.
54. Klipstein FA. Tropical sprue in travelers and expatriates living abroad. Gastroenterology 1981;80:590-600.
55. Rickles FR, Klipstein FA, Tomasini J, Corcino JJ, Maldonado N. Long-term followup of antibiotic-treated tropical sprue. Ann Intern Med 1972;76:203-210.
56. Klipstein FA, Holdeman LV, Corcino JJ, Moore WE. Enterotoxigenic intestinal bacteria in tropical sprue. Ann Intern Med 1973;79: 632-641.
57. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-1234.
58. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-980.
59. Jawad AS, Hamour AA, Wenley WG, Scott DG. An outbreak of acute sarcoidosis with arthropathy in Norfolk [letter]. Br J Rheumatol 1989;28:178.
60. Hills SE, Parkes SA, Baker SB. Epidemiology of sarcoidosis in the Isle of Man - 2: evidence for space-time clustering. Thorax 1987;42: 427-430.
61. Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation [letter]. Lancet 1990;336:1579.
62. Heyll A, Meekenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:161-164.
63. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction [comments]. Lancet 1992;339:1012-1015.
64. Ghossein RA, Ross DG, Salomon RN, Rabson AR. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994;101:733-737.
65. Lisby G, Milman N, Jacobsen GK. Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification. Apmis 1993;101:876-878.
66. DeRemee RA, McDonald TJ, Weiland LH. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 1985;60:27-32.
67. West BC, Todd JR, King JW. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. Ann Intern Med 1987;106:840-842.
68. DeRemee RA. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum 1988;31:1068-1074.
69. Leavitt RY, Hoffman GS, Fauci AS. The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. Arthritis Rheum 1988;31:1073-1074.
70. Stegeman CA, Cohen TJ, de Jong PE, Kallengerg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20.
71. Kloppenburg M, Dijkmans BA, Breedveld FC. Antimicrobial therapy for rheumatoid arthritis. Baillieres Clin Rheumatol 1995;9: 759-769.
72. Trentham DE, Dynesius TR. Antibiotic therapy for rheumatoid arthritis. Scientific and anecdotal appraisals. Rheum Dis Clin North Am 1995;21:817-834.
73. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1994; 37:629-636.
74. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group [comments]. Ann Intern Med 1995;122:81-89.
75. Rook GA, Stanford JL. Slow bacterial infections or autoimmunity? Immunol Today 1992; 13:160-164.
76. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity [published erratum appears in Immunol Today 1988;9:277]. Immunol Today 1988;9:178-182.
77. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Ouinn TC. Replication of Chlamydia pneumonias in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-1620.
78. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Infect Immun 1996;64:1614-1620.
79. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978;148:335-340.
80. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Bioessays 1995;17:899-903.
81. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-174.
82. Koskinen PK, Nieminen MS, Krogerus LA, et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993;12:724-729.
83. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335:624-630.
84. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-394.
85. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116:273-278.
86. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-849.
87. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumomae/Atherosclerosis Study Group. Ann Intern Med 1996;125:979-982.
88. Moazed TC, Kuo C, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997; 175:883-890.
89. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumonlae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;6:404-407.
90. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404-407.